...purpose acquisition company GX Acquisition Corp. (Nasdaq: GXGX). A syndicate including Starr Insurance Companies, Dragasac Ltd. and Sorrento Therapeutics Inc....

...Inc. miRagen Therapeutics Inc. CerRx Inc. Innate Pharma S.A. BioCryst Pharmaceuticals Inc. Johnson & Johnson 4SC AG Medivir AB Bioniz Therapeutics Inc. Codiak BioSciences Inc. Sorrento Therapeutics Inc. Trillium...

...gene therapy offerings, which include the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm...

...By Robin Sawka, BioCentury Staff Sorrento Therapeutics Inc. (NASDAQ:SRNE) terminated Jiong Shao as EVP and CFO. He is succeeded as...
...He is succeeded as CFO by Najjam Asghar, who is the company’s chief accounting officer. Sorrento...
...Technologies Inc. hired Julianne Averill as CFO. She was VP of finance at BlackThorn Therapeutics Inc. Robin Sawka Sorrento Therapeutics Inc. Kronos...

...these technologies for that use. On July 29, Sorrento Therapeutics Inc....

...and vaccines. The newest preclinical vaccines in the pipeline include the protein-based T-VIVA-19 vaccine from Sorrento Therapeutics Inc....

...inhibitor Sorrento Therapeutics Inc. (NASDAQ:SRNE) entered a binding term sheet with ACEA Therapeutics Inc. that would give Sorrento...
...neuron 1 telomeric SMN2 - Survival of motor neuron 2 centromeric Robin Sawka, BioCentury Staff Kadmon Holdings Inc. Sorrento Therapeutics Inc. Novartis...

...platforms that promote antigen uptake and presentation by endogenous APCs. A "decoy cell" vaccine from Sorrento Therapeutics Inc....

...an area under the curve (AUC) of 95%. Sorrento spikes on data for anti-spike antibody Sorrento Therapeutics Inc....
...CRP - C-reactive protein Env - HIV env GALC - Galactosylceramidase LDH - Lactate dehydrogenase BioCentury Staff Sorrento Therapeutics Inc. NIH Duke...

...on Wednesday a partnership with the U.S. government to develop the therapy. Meanwhile, Vir and Sorrento...
...a non-exclusive license to Xtend for COVID-19 mAbs. Financial terms were undisclosed. Sorrento’s COVID-19 vaccine Sorrento Therapeutics Inc....
...enzyme 2 (ACE2), the host protein that the spike binds to mediate viral cell invasion. Sorrento...